A Switch Of Kings? NZ Explores First-In-World Gout Medicine Rx-To-OTC Reclassification
Could New Zealand become first country to switch gout medicine allopurinol from Rx to OTC status? HBW Insight speaks to applicant and global switch expert Natalie Gauld.
You may also be interested in...
Australia's Therapetics Goods Administration finalizes its decision to regulate low-dose CBD as an OTC medicine, raising the maximum daily dose to 150mg. The move is welcomed by the country's self-care industry.
A wide-ranging study of low-dose cannabidiol supplementation, its regulation, efficacy and safety calls for improved legislation, guidelines and quality control together with clinical trials exploring the increasingly popular ingredient's therapeutic benefits.
Switch expert Natalie Gauld says recent triptan switch recommendations signal a turnaround for Australia's OTC market.